FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 2072614 · Received April 22, 2011

Report

Report Number
3004464228-2011-00171
Event Type
Malfunction
Date Received
April 22, 2011
Date of Event
March 22, 2011
Report Date
March 22, 2011
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K042792
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THE EVAL OF THE RETURNED PRODUCT FOUND EVIDENCE OF AN INTERNAL FLUID LEAK, INCLUDING DISCOLORATION INSIDE THE DEVICE AND CORROSION AND RESIDUAL FLUID ON THE SURFACES OF INTERNAL ASSEMBLIES. A LEAK TEST WAS PERFORMED WHICH CONFIRMED A LEAK IN THE FLUID PATH. A TEAR WAS FOUND IN THE CANNULA TUBING. THIS WOULD RESULT IN INSULIN COMING INTO CONTACT WITH INTERNAL COMPONENTS AND ASSEMBLIES, ULTIMATELY CAUSING THE DEVICE TO FAIL. A DEVICE MALFUNCTION IS THEREFORE CONFIRMED AS A CONTRIBUTING FACTOR TO THE CUSTOMER'S HIGH BLOOD GLUCOSE. THERE WAS EVIDENCE OF THIS DEFECT MODE IN LOT ACCEPTANCE TESTING FOR THE POD LOT (L30453); RESULTS WERE DEEMED ACCEPTABLE. RISK LEVEL TO THE PT WAS DETERMINED TO BE EXTREMELY LOW (1.35 IN 10,000). DIABETICS ARE TRAINED TO MONITOR THEIR BGS ON A REGULAR BASIS. INSULET PROVIDES LABELING REFERENCING THIS MONITORING. ADDITIONALLY, THE PRODUCT LABELING INSTRUCTS THE CUSTOMER TO "TAKE A SECOND BOLUS BY INJECTION USING A STERILE SYRINGE" IF A DEVICE-ADMINISTERED BOLUS HAS NOT CORRECTED A HIGH BG CONDITION AFTER TWO HRS AND, "IF BLOOD GLUCOSE REMAINS HIGH AFTER ANOTHER 2 HRS (A TOTAL OF 4 HRS), REPLACE THE POD." INSULET HAS INITIATED AN INTERNAL INVESTIGATION TO IDENTIFY THE ROOT CAUSE OF THIS FAILURE MODE. THE INVESTIGATION IS IN PROCESS AS OF THE DATE OF THIS REPORT.

Description of Event or Problem · 1

CUSTOMER CALLED IN TO ASK WHETHER TO REPLACE THE DEVICE. SHE HAD BEEN BOLUSING (EXACT TIMES AND DOSAGES UNK) AND HER BLOOD GLUCOSE WAS MEASURING "HIGH".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 11200 L30453

Patients

Seq Age Sex Outcome Treatment
1 58 YR Other